COLINZ Stock View

Colinz Laboratories Ltd
stock-view-header

icon -1.19 | -2.96
Market Cap ₹( Cr.)
101.24
Proj. P/E (x)
Proj. P/BV (x)
Proj. ROE (%)
Proj EV / EBITDA (x)
--
Proj. Revenue ( Cr.)

Stock View

Last Updated On.
18-Feb-2024
 

The average score for Colinz Laboratories Ltd stands at 10 against 8, three months back.

Colinz Laboratories Ltd. is an India-based company that is engaged in the manufacturing and marketing of pharmaceutical formulations particularly in gynecological sector. The Company is engaged in the manufacturing and marketing various allopathic and ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals and ointments, among others. It provides physicians with products in the treatment of hypertension, cholesterol, diabetes, piles, pyrexia and malaria. It provides gynecologists with specialized products in the treatments of morning sickness, infertility, intrauterine growth restriction (IUGR) and maintenance of pregnancy. It also offers other products, such as hematinic, antispasmodics, anti-inflammatory/anti-allergic tablets, capsules gel and medicated shampoo. The Company markets its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, Madhya Pradesh, Chhattisgarh and West Bengal through its own marketing staff.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.


Technical Data

50 DMA(₹)
40.49
100 DMA(₹)
40.48
200 DMA(₹)
39.27
52 Weeks Range
33.35     44.00

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required